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Abstract
In vertebrates, insufficient availability of calcium and inorganic phosphate ions in extracellular
fluids leads to loss of bone density and neuronal hyper-excitability. To counteract this problem,
calcium ions are usually present at high concentrations throughout bodily fluids – at concentrations
exceeding the saturation point. This condition leads to the opposite situation where unwanted
mineral sedimentation may occur. Remarkably, ectopic or out-of-place sedimentation into soft
tissues is rare, in spite of the thermodynamic driving factors. This fortunate fact is due to the
presence of auto-regulatory proteins that are found in abundance in bodily fluids. Yet, many
important inflammatory disorders such as atherosclerosis and osteoarthritis are associated with
this undesired calcification. Hence, it is important to gain an understanding of the regulatory
process and the conditions under which it can go awry. In this manuscript, we extend mean-field
continuum classical nucleation theory of the growth of clusters to encompass surface shielding.
We use this formulation to study the regulation of sedimentation of calcium phosphate salts in
biological tissues through the mechanism of post-nuclear shielding of nascent mineral particles by
binding proteins. We develop a mathematical description of this phenomenon using a countable
system of hyperbolic partial differential equations. A critical concentration of regulatory protein
is identified as a function of the physical parameters that describe the system.
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I. INTRODUCTION
In biology, ionic calcium (Ca2+ ) plays many diverse roles including acting as a secondary
messenger in biochemical cascades and modulating neuronal excitability [1]. Structurally,
Ca2+ and inorganic phosphate ions (PO–4) are also the main constituents of bones in verte-
brates. For this reason, it is important for organisms to obtain adequate amounts of calcium
from the environment.
In normal circumstances, Ca2+ is plentiful throughout extracellular spaces and in the
circulatory system, stably existing at concentrations exceeding the saturation point, whereby
sedimentation is favored [2]. Even under the dangerous condition of hypocalcemia, Ca2+
may still be supersaturated relative to the most thermodynamically stable phase of calcium
phosphate, hydroxyapatite (HAP), which is the building block of teeth and bones.
Yet, while the deposition of calcium into bones is desirable, ectopic calcification into soft
tissues is pathological and either causes or exacerbates a variety of inflammatory disorders
including arteriosclerosis, heart disease, and arthritis [3–5]. So, the regulation of ectopic
calcium sedimentation is important in maintaining the health of soft tissues.
When calcium-phosphate solutions are supersaturated, HAP is formed in a multi-step
process traversing through several intermediate crystalline or psuedo-crystalline states. The
first step in this process is thought to be formation of pre-nucleation clusters [6–8], which are
small calcium-phosphate complexes [9]. Although some debate exists [7, 8, 10], these small
complexes are thought to be Posner’s clusters (PC), with composition Ca9(PO4)6 [11]. A
combination of experimental and theoretical analyses have confirmed the stability of PCs [12,
13], their presence in physiological solutions [11], and their consistency with the unit-cell
structure of calcium-phosphate precipitates [6, 14]. For the purposes of this manuscript, we
will assume that PCs are the fundamental building blocks of larger-scale calcium-phosphate
clusters and refer to them as monomers.
These monomers aggregate whereby they nucleate into amorphous spherical post-
nucleation clusters composed of amorphous calcium phosphate (ACP) [15–18], having a
calcium to phosphate ratio of approximately three to two [19]. As long as supersaturation
persists, and in the absence of regulation, ACP clusters continue to grow by absorbing ad-
ditional monomers into their structure. When ACP clusters become sufficiently large, they
sediment into the tissue while simultaneously undergoing several phase transitions before
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eventually transforming into HAP.
This situation is seemingly incompatible with life as the persistent supersaturation of
calcium and phosphate in biological fluids dictates unyielding sedimentation, at least in the
absence of regulatory inhibition. Fortunately a regulatory mechanism does exist. The main
machinery for preventing calcium phosphate sedimentation is the plasma protein fetuin-
A (FA) [5, 20–23]. FA is an acidic protein that is found abundantly in blood as well as
throughout all extracellular compartments. Maintenance of adequate levels of FA protein
has been shown to be necessary for inhibition of calcification in relation to many disorders [24,
25].
FA interacts with the calcium phosphate mineralization process in several different ways.
It can directly bind calcium, with each molecule able to weakly and reversibly bind approx-
imately 12–15 ions [26]. Yet, this direct binding of calcium cannot be the main regulatory
mechanism of FA as it would effectively reduce the supersaturation. There is also evidence
that FA binds to pre-nucleation clusters [22], a possibility that has been analyzed [27], al-
though somewhat contradictory evidence has also shown that the presence of FA does not
affect the rate of nucleation of calcium phosphate clusters [28]. Primarily, FA binds strongly
to post-nuclear calcium-rich calcium-phosphate clusters, shielding them from further growth
and imparting upon them enhanced colloidal stability so that they do not sediment.
In this manuscript, we adapt mean-field classical nucleation theory (CNT) to look at the
inhibition of mineral cluster growth by FA. We provide a quantitative description of the
overall regulatory process and examine conditions necessary for stability.
II. QUANTITATIVE METHODS
The problem of understanding the combined process of mineralization and FA-induced
inhibition is an example of a nucleation problem. Our approach to this problem is to
use ideas from mean-field classical nucleation theory (CNT). In particular, we utilize a
continuum approximation to the kinetic theory whereby we frame our problem using a
series of serially-coupled partial differential equations (PDE). It is notable, however, that
theoretical treatments of the inherently high-dimensional stochastic problem of nucleation
and aggregation also exist [29–31]. The mean-field theoretic CNT approach is ultimately
motivated by the behavior of such stochastic treatments.
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Our overarching goal in this section is to understand the kinetics of the concentration
profile for mineral clusters as a function of size and interactions with FA. To this end, in
Section II A, we first solve for the nucleation rate (formation rate of critically-sized clusters),
which provides a boundary condition for our PDE problem. Then, in Section II B, we derive
an effective growth rate (vn(s)) for the mineral portion of formed mineral and protein-mineral
clusters as a function of their fixed mineral surface area s and number of bound FA proteins
n. Then, in Section II C, for a fixed cluster configuration, we derive the shielding rate under
the assumption that it is governed by diffusion-limited kinetics. Finally, in Section II D, we
tie together the various components of our theory (nucleation, growth, shielding) into an
overarching continuum model.
For the reader’s convenience, we have compiled a list of the mathematical symbols that
we use throughout this manuscript into Table I.
A. Nucleation
CNT explains the emergence and evolution of colloidal phases in solutions through the
development of a simple thermodynamical picture. The key element of CNT is the assump-
tion that the emergence of a new phase carries an energetic cost due to the creation of an
interfacial surface.
Consider a mineral particle consisting of an integer number m mineral subunits, hereby
termed an “m-cluster.” We say that this particle has volume V = mv¯, where v¯ is the
effective volume of each subunit “monomer.” Assuming that this particle is spherical, it has
surface area s = (36v¯2pi)1/3m2/3, and radius r =
√
s/4pi. In this manuscript, we use both
m and s to parameterize the size of mineral clusters (see Fig. 1). We also will refer to the
conversion between these two parameterizations as m(s) and s(m).
For an m-cluster, CNT assigns as per the capillary approximation the free energy
∆G =
∆Gγ︷︸︸︷
γfs +
∆Gµ︷ ︸︸ ︷
m∆µ =
spherical︷ ︸︸ ︷
γfs+
∆µ
6v¯
√
pi
s3/2, (1)
where ∆µ is the molecular free energy per monomer in the cluster relative to in the solution
(in units kBT ), v¯ is the volume per monomer, γ > 0 is the interfacial surface energy per
unit area (in units kBT per square meter), and f is a geometric factor than can be adjusted
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Symbol Description
s Surface area of mineral phase of cluster
m Number of mineral monomers in a cluster, where
monomer refers to Posner’s cluster Ca9(PO4)6.
r Radius
V Volume
n Number of shielding proteins attached to surface of
cluster
γ Interfacial free energy per unit surface area in units
kBT per squared meter
f Geometric correction for surface free energy for
non-spherical pre-critical states
ρ∞ Concentration of mineral monomers
ρs Saturation concentration
∆µ − log(ρ∞/ρs), Chemical free energy per mineral
monomer in units kBT
∆G Gibbs free energy in units kBT
cn(s, t) Concentration of mineral clusters
of surface area s shielded by n FA monomers
s′ Shielded surface area
sn Amount of surface shielded (s′) when n
FA monomers are bound
δsn sn − sn−1 for n ≥ 1
s∗,m∗ Critical cluster size at nucleation
sp,mp Critical cluster surface area and monomer number
at sedimentation
D Diffusivity of mineral monomers
DFA Diffusivity of FA monomers
k− Dissociation rate per unit surface area for mineral
φ∞ Concentration of FA monomers
r¯, s¯, v¯ Mineral monomer radius, surface area, volume
ω D
√
4piρs/k−
α 8v¯Dpiρ∞
β −∆µ√s∗/f
ε Thickness of shielding layer (of FA protein)
λ
√
4piDFAφ∞
TABLE I: List of mathematical symbols used in the manuscript for easy reference
to account for non-spherical growth in the pre-nucleation stage as well as size-dependent
variations in the surface free energy [32]. For constant supersaturation, ∆µ < 0 so that
∆G → −∞ as s →∞, thereby thermodynamically favoring the existence of large clusters.
Yet, as shown in Fig. 2(a), the state of pure-monomers (s = 0) is also a local minimum of this
free energy. The emergence of clusters is governed by kinetic rather than thermodynamic
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Mathematical model for calcification and regulation Solution and Results
Reparameterization
Total consumption = FA consumed by clusters of size m⇤
+ FA consumed by clusters of size m⇤ + 1
+ FA consumed by clusters of sizem⇤ + 2
+ . . .
Joshua C. Chang (MBI) Allen Institute science talk January 21, 2015 34 / 50
m parameterizations parameterization
FIG. 1: Cluster size parameterizations. Surface area (s) and monomer count (m) parameterizations
are used interchangeably for expressing the size of mineral clusters. Clusters are assumed to be spherical
and composed of an integer number m of monomers (Posner’s clusters). The cluster as a whole has surface
area s. To denote the conversion between these two parameterizations we use functions m(s) : s→ m and
s(m) : m→ s.
considerations as an energy barrier of ∆Gcrit corresponding to the free energy of a critical
cluster with size s∗ must be overcome. This barrier is overcome when a cluster reaches a
size m = m∗, s = s∗. The steady-state mean-field rate at which clusters reach this size is
exponential in the magnitude of the energy gap and is known as the Zeldovich rate
j∗ = κ exp (−∆Gcrit) (2)
where κ is a constant with units of concentration per time [33]. While the presence of
pre-nucleation clusters in the calcium phosphate system violates the assumptions of CNT,
Habraken et al. [8] showed that CNT is still applicable with the use of some minor modifica-
tions that result in the reduction of the effective energy gap. Hence, we will assume for the
purposes of this manuscript that critically sized clusters of size s∗ are forming spontaneously
at some rate in the form of Eq. 2.
In the blood and extracellular compartments, fluid is under constant exchange. For this
reason, we will also assume that the supersaturation is constant, and hence that j∗ and s∗
are fixed, and study the growth of clusters after their nucleation.
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FIG. 2: Nucleation, growth, and shielding. (a) Classical nucleation of an initial critically-sized
spherical mineral cluster of surface area s∗ (≈ 3nm2). The activation energy ∆Gcrit (units of kBT )
corresponds to the energy of the cluster of critical size (of units surface area). A flux j∗ of nucleating
particles is generated by the system under the condition of supersaturation. (b) Unregulated growth.
Upon nucleation, particles grow uncontrollably at a size dependent rate v0(s) as defined in Eq. 22. (c)
The attachment of proteins (shielding) alters the growth rate. The growth rate of the mineral
vn(s) depends on the size s of the mineral phase as well as the number of attached FA monomers n. The
attachment of an additional protein to a cluster shielded by n proteins shields an additional surface area of
size sn+1 − sn. Completely-shielded particles, where the surface area s is less than the shielding capacity
sn, do not grow.
B. Growth of the mineral phase
An m-cluster (of surface area s(m)) may find itself caked by a number of proteins, which
effectively shield a surface area s′ ≤ s(m). Our immediate goal is to compute an effective
growth rate for this particle assuming its shielding its fixed. We will assume that each
successive protein shields a maximal surface area δsn = sn − sn−1. In other words, if n
proteins are attached, then a total surface area of size s′ = sn is shielded from further free
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monomer adsorption.
Due to surface reactions, this particle experiences an instantaneous net flux of monomers
into its structure
J = k+(s, s
′)ρr︸ ︷︷ ︸
absorption
− k− × (s− s′)︸ ︷︷ ︸
dissociation
(3)
where ρr is the concentration of free monomers at the surface, k− is the dissociation rate
per unit surface area, and k+(s, s
′) is the absorption rate which is dependent on m as well
as the free surface area.
To begin, we will eliminate the unknown physical parameter function k+(s, s
′) by using
equilibrium considerations to relate it to the other physical parameter k−. There exists a
critical monomer concentration ρm at which an m-cluster is at equilibrium with its surround-
ings so that
k+ρm − k−(s− s′) = 0. (4)
At the equilibrium concentration, the free energy gap between clusters of size m and m+ 1
also disappears so that,
δG = ∆µ+ (36v¯2pi)1/3γ((m+ 1)2/3 −m2/3) = 0, (5)
where ∆µ = log(ρs/ρm) is the chemical potential, and ρs is the free monomer concentration
at saturation (where the solution is in equilibrium with in infinitely-large cluster). Eq. 5
implies that
ρm = ρs exp
[
(36v¯2pi)1/3γ((m+ 1)2/3 −m2/3)]
= ρs exp
[
−∆µ
f
(m∗
m
)1/3(
1− 1
6m
+O(m−2)
)]
= ρ∞ exp
{
∆µ
[
1− 1
f
(m∗
m
)1/3]}
× exp
{
∆µ
f
(m∗
m
)1/3 [ 1
6m
+O(m−2)
]}
. (6)
Substitution of ρm from Eq. 6 into Eq. 4 yields the expression for k+,
k+ =
k−(s− s′)
ρs exp[−∆µ
√
(s∗/s)/f ]
(
1 +O(m−4/3)) . (7)
Eq. 7, substituted into Eq. 3, allows us to write the flux of monomers into the mineral cluster
J ≈ k−(s− s′)
ρr − ρs exp
(
β√
s
)
ρs exp
(
β√
s
)
 (8)
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as a function of the physical dissociation constant k−, the free monomer saturation concen-
tration at saturation ρs, and the free monomer concentration at the surface of the mineral
ρr, and
β = −∆µ
√
s∗
f
. (9)
The concentration ρr is found through conservation of monomer mass by flux matching as
in Fig. 3 in the quasi-steady diffusive limit, where the FA protein forms a shielding layer
around the mineral of thickness ε. At a distance x from the center of the mineral, outside
of the shielding layer (x > r + ε), the free monomer flux obeys Fick’s law
J = 4pix2D∂xρ = 4piD
(r + δ)(r + ε)
δ − ε (ρ∞ − ρε)
= 4piD(r + ε)(ρ∞ − ρε) +O
(
r + ε
δ − ε
)
, (10)
where the second equality is obtained by integration of the concentration from x = r + ε to
x = r + δ, where δ  r is the thickness of the diffusion layer. At the surface, the flux is
given by Eq. 8. Invoking free monomer conservation, by equating Eq. 8 with Eq. 10, while
also assuming that ε is small relative to the characteristic diffusion length (ρr ≈ ρε), allows
us to solve for the monomer concentration at the mineral surface,
ρr ≈ ρs 4piD(r + ε)ρ∞ + k−(s− s
′)
4piD(r + ε)ρs exp
(
β√
s
)
+ k−(s− s′)
exp
(
β√
s
)
. (11)
In Eq. 11, one sees that as D →∞, the concentration at r goes to ρ∞, as expected. Plugging
the concentration from Eq. 11 into Eq. 8 yields the growth rate
V˙ = v¯J ≈ k−(s− s′)
[
4piv¯D(r + ε)(ρ∞ − ρseβ/
√
s)
4piD(r + ε)ρseβ/
√
s + k−(s− s′)
]
. (12)
While clusters of any size can be shielded, entirely-shielded clusters below the size s = s1
are not of our concern because they are inert (recall that the first protein shields a maximal
surface area of size s1). Hence, we only wish to find the shielded growth rate when s > s1.
Making the assumption that ε is small relative to r, for r =
√
s/4pi >
√
s1/4pi, yields the
volume growth rate in terms of s,
V˙ ≈ 1√
16pi
αs1/2(s− s′)(1− ρseβ/
√
s/ρ∞)
ωs1/2eβ/
√
s + (s− s′) ,
with constants
ω = D
√
4piρs/k−, (13)
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and
α = 8v¯Dpiρ∞. (14)
Note that in the limit as s− s′  ωs1/2eβ/√s, this growth rate is surface-limited, whereas
in the limit as s−s′  ωs1/2eβ/√s, growth is diffusion limited. The parameters ω and β define
the length-scale under which surface-limited effects are significant. Typically, in nucleation
problems, the surface-limited regime is ignored as it is usually only important when the
particle is small. For the purposes of our system, we take a cue from the study of Treboux
et al. [13], which showed that aggregation of PCs is highly favorable energetically, and assume
that aggregation of post-nuclear PCs is diffusion limited. However, the surface-limited effects
can become significant at larger particle sizes for clusters that are nearly-completely shielded.
In this regime, we note that eβ/
√
s ≈ 1, allowing us to use the simplified growth rate
V˙ ≈ 1√
16pi
αs1/2(s− s′)
ωs1/2 + (s− s′) . (15)
The surface area growth rate is related to the volume growth rate through the chain rule,
vn(s) =
√
16pi
s
V˙ ≈ α(s− sn)
ωs1/2 + (s− sn) . (16)
C. Shielding by the protein phase
In this section, we compute the FA shielding rate for a fixed cluster configuration. The
shielding of the mineral phase by FA can be understood in a manner similar to the growth
of the mineral phase. The overall adsorption rate of FA monomers onto the surface results
from a balance between the diffusive supply and the surface reactions. Assuming first that
mineral clusters have less mobility than FA, and denoting the diffusivity of FA by DFA, one
may use similar reasoning as in the previous section to find the overall attachment rate of
FA. As before, we may express the flux into the surface as a balance between two competing
reactions through a conservation law
JFA = konφr(s− s′)− koffs′ (17)
where kon is the binding rate of FA to the mineral per unit free surface area per unit
concentration, koff is the dissociation rate of FA, φ∞ is the far-field heat bath concentration
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FIG. 3: Shielded diffusion-limited growth. FA protein forms a diffusion barrier of height ε and
surface area s′ = sn, where n is the number of associated proteins, around the mineral cluster. The
absorption rate k+ρr per unit surface area of the growth units depends on the local concentration ρr of
growth units at the surface of the particle. Dissociation also occurs at rate k− per unit surface area.
Neither absorption nor dissociation occur in the shielded region (red). For ε sufficiently small, ρr ≈ ρε.
The concentration ρr is then determined through conservation of flux. Outside of the diffusion layer (of
thickness δ  r), the concentration of growth units approaches ρ∞.
of FA, and φr is the concentration at the surface. By Eq. 10, we may also write the diffusive
flux
JFA ≈ DFA
√
4pis(φ∞ − φr), (18)
which, through conservation, matches the reaction flux of Eq. 17. Equating Eq. 17 and
Eq. 18 allows us to solve for the surface concentration of FA,
φr ≈ DFA
√
4pisφ∞ + koffs′
kon(s− s′) +DFA
√
4pis
. (19)
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Back-substituting Eq. 19 into Eq 17 yields the overall rate
JFA ≈ kon(s− s′) DFAφ∞
√
4pis+ koffs
′
kon(s− s′) +DFA
√
4pis
− koffs′. (20)
At this stage we make a few simplifying assumptions – namely that the overall shielding
process is diffusion-limited in the regime of most interest (where 0 ≤ s′ < s < sp). First
we remind the reader that our continuous formulation is an approximation of an underlying
discrete system. For this reason, we note that the unshielded area s − s′ cannot become
infinitesimal. This fact allows us to make the assumption that the binding reaction is always
sufficiently fast such that kon(s− s′) DFA
√
4pis, for s ≤ sp.
Finally, we will assume that the rate of detachments is negligible (irreversible binding
of FA to mineral clusters). Altogether, these assumptions allow us to write the simpler
diffusion-limited shielding rate rule
JFA ≈ DFA
√
4pisφ∞. (21)
Strictly speaking, the parameters φ∞ and ρ∞ contained in these expressions are them-
selves dynamical variables. Their evolution can be determined through mass conservation,
as all changes are due to the balance between supply and consumption. We are interested
however in the biologically-relevant situation where calcification is a local phenomenon cou-
pled to global auto-regulatory processes that maintain supersaturation. For instance, fluid
present in a knee joint is continually replenished through interstitial flow. That is to say,
we set φ∞ and ρ∞ constant and examine the conditions for the regulation of sedimentation
in this regime.
D. Overall continuum model
Classical work by Landau, Lifshitz [34], defined an advection problem to quantitatively
describe the evolution of the cluster concentrations as clusters grow due to monomer ab-
sorption. This work has been extended throughout the years [35], and recently united with
nucleation [36, 37], which is introduced as an effective boundary condition. We further ex-
tend this prior work by incorporating the effects of shielding. In this continuum approach,
one may describe the evolution in size of the concentration profile of clusters using an ad-
vection equation, where the cluster growth rate provides an effective “velocity” or drift.
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Overall, the dynamic concentration cn(s, t) of clusters of mineral surface area s associated
with n FA monomers is described for all non-negative integers n ≥ 0 for s > sn by the
partial differential equations indexed by n,
∂cn(s, t)
∂t
+
∂
∂s
[ vn(s)︷ ︸︸ ︷α(s− sn)
ωs1/2 + (s− sn) cn(s, t)
]
=
−λs1/2 (cn(s, t)− cn−1(s, t))︸ ︷︷ ︸
diffusion limited
(22)
where vn(s) is surface growth rate dependent on the number of bound FA monomers, s
′ = sn
for n ≥ 1 and s′ = 0 for n = 0,
λ =
√
4piDFAφ∞, (23)
and for notational convenience we set c−1(s, t) ≡ 0. The right-hand-side describes diffusion-
limited shielding of the mineral particles by FA protein, which is assumed to have high
affinity for the mineral phase. The solution domain for Eq. 22 is shown in Fig. 2(c). For our
purposes, we will assume that the system starts at a reference time t = t0 at the the initial
state
cn(s, t0) =
0 s > s∗c∞0 (s∗) s = s∗, (24)
where c∞0 (s∗) is an equilibrium concentration set by the nucleation process.
Critically-sized clusters (of size s∗) are assumed to be created at the Zeldovich rate j∗ of
Eq. 2. This creation rate is balanced with consumption due to growth and shielding. As in
Farjoun and Neu [36], this growth flux is expressed in terms of the non-dimensional rate of
number-growth, V˙ /v¯ of Eq. 15. Invoking their balance argument leads to the constraint
j∗ = lim
s↘s∗
[(
DFAφ∞
√
4pis
+
√
4piDρ∞s3/2
ωs1/2 + s
)
c0(s, t)
]
. (25)
Hence, the combined effects of nucleation and shielding impose an effective Dirichlet bound-
ary condition
c∞0 (s∗) ≡ c0(s∗, t)
= j∗
[
λ
√
s∗ +
√
4piDρ∞s
3/2
∗
ωs
1/2
∗ + s∗
]−1
. (26)
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III. RESULTS
In this section we construct a solution to the system of partial differential equations de-
fined in Eq. 22 and the boundary conditions defined in Eqs. 24–26. We proceed first by
non-dimensionalization of the problem formulation. Then, using the method of characteris-
tics, we derive a sequential relationship between the solutions of the system. Approximating
the solution of the system of equations, we analyze the steady-state behavior of the system
in the limit where inhibition is sufficiently strong, from which we compute the overall rate of
protein consumption and propose a criterion for effective inhibition of calcification. Finally,
we parameterize our equations using experimentally measured values found in the literature.
A. Nondimensionalization
We seek a convenient non-dimensionalization of our serial system of PDEs describing the
shielded growth problem. We begin by normalizing the surface area s, which ranges between
the critical nucleation surface area s∗ and another critical surface area sp which represents
the surface area at sedimentation. Using these constants, we write the non-dimensionalized
size variable
sˆ =
s− s∗
sp − s∗ (27)
critical cluster size s∗,
sˆ∗ =
s∗
sp − s∗ , (28)
shielded surface area,
sˆ′ =
s′
sp − s∗ , (29)
shielding levels s′ = sn,
sˆn =
sn
sp − s∗ , (30)
and surface-limiting parameter ω
ωˆ =
ω√
sp − s∗ . (31)
Rescaling time
tˆ =
α(t− t0)
sp − s∗ (32)
results in the series of non-dimensional advection equations of asymptotically unit speed,
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∂cˆn
∂tˆ
+
∂
∂sˆ
[
(sˆ+ sˆ∗ − sˆn)cˆn(sˆ, tˆ)
ωˆ(sˆ+ sˆ∗)1/2 + (sˆ+ sˆ∗ − sˆn)
]
= −λˆ
√
sˆ+ sˆ∗
(
cˆn(sˆ, tˆ)− cˆn−1(sˆ, tˆ)
)
(33)
with non-dimensional shielding constant
λˆ =
λ(sp − s∗)3/2
α
(34)
where the concentrations have been scaled by the nucleation boundary condition
cˆn(sˆ, tˆ) =
cn(s(sˆ), t(tˆ))
c∞0 (s∗)
, (35)
so that the concentration of critical clusters is fixed
cˆ0(0, tˆ) = 1. (36)
B. Characteristics of the PDE system
The non-dimensionalized partial differential equations of Eq. 33 can be solved by invoking
the method of characteristics sequentially for each PDE. The solutions to the PDEs contain
the characteristic curves described by the equations
dsˆ
dtˆ
=
(sˆ+ sˆ∗ − sˆ′)
ωˆ(sˆ+ sˆ∗)1/2 + (sˆ+ sˆ∗ − sˆ′) . (37)
The sˆ − tˆ characteristics, as shown in Fig. 4, originate from points (tˆ0, sˆ(tˆ0)). They follow
the relationship
tˆ− tˆ0 = sˆ− sˆ(tˆ0) + 2ωˆ
[√
sˆ+ sˆ∗ −
√
sˆ(tˆ0) + sˆ∗
]
+ ωˆsˆ′ log
√sˆ+ sˆ∗ −√sˆ′√
sˆ+ sˆ∗ +
√
sˆ′
√
sˆ(tˆ0) + sˆ∗ +
√
sˆ′√
sˆ(tˆ0) + sˆ∗ −
√
sˆ′
 . (38)
Particularly, for unshielded clusters (where sˆ′ = 0), the last line of Eq. 38 is zero.
Along these curves, the concentration varies as
dcˆn
dtˆ
= − ωˆ
2
√
sˆ+ sˆ∗
sˆ+ sˆ∗ + sˆ′[
ωˆ
√
sˆ+ sˆ∗ + sˆ+ sˆ∗ − sˆ′
]2 cˆn(tˆ)
− λˆ
√
sˆ+ sˆ∗
(
cˆn(tˆ)− cˆn−1(sˆ, tˆ)
)
. (39)
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FIG. 4: Characteristics for advection problem. Some sample sˆ− tˆ characteristics for the
nondimensionalized PDE problem with sˆn − sˆ∗ = 0.25. For (a) n = 0, and characteristics emerge from
sˆ = sˆ∗. For (b) n ≥ 1, the characteristics emerge from the curve {(sˆ, tˆc(sˆ))}, where tˆc is given in Eq. 47.
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For the purpose of solving these equations, it is advantageous to invoke the change-of-
variables
u ≡
√
sˆ+ sˆ∗ (40)
sˆ′ ≡ sˆn (41)
ds = 2udu, (42)
to reparameterize the curves as
dtˆ
du
= 2u
[
ωˆu
u2 − sˆn + 1
]
≥ 0 ∀u >
√
sˆn, (43)
from where it is evident that the relationship between tˆ and u is bijective. Hence, we may
use u as a proxy for tˆ, finding that the concentration profiles along these curves vary with
u as
dcˆn
du
=
−
[
ωˆ
u2 − sˆn
u2 + sˆn
ωˆu+ u2 − sˆn + 2λˆu
2u
2 + ωˆu− sˆn
u2 − sˆn
]
cˆn
+ 2λˆu2
u2 + ωˆu− sˆn
u2 − sˆn cˆn−1(sˆ(u), tˆ(u)). (44)
With the aid of an integrating factor, Eq. 44 can be written in the exact differential form
d
{
(u2 − sˆn)λˆωˆsˆn+1
u2 + ωˆu− sˆn exp
[
λˆu2
(
ωˆ +
2
3
u
)]
cˆn
}
= 2λˆu2(u2 − sˆn)λˆωˆsˆn exp
[
λˆu2
(
ωˆ +
2
3
u
)]
cˆn−1(u, tˆ(u)). (45)
The equation for the unshielded particle concentration cˆ0 corresponds to the homogeneous
problem (sˆ0 ≡ 0; cˆ−1 ≡ 0). Respecting the boundary condition invoked by nucleation, as
well as the initial Cauchy data, yields the solution
cˆ0(sˆ, tˆ) = H
(
tˆ− tˆc(sˆ)
) ωˆ +√sˆ+ sˆ∗√
sˆ+ sˆ∗
√
sˆ∗
ωˆ +
√
sˆ∗
×
exp
[
λˆsˆ∗
(
ωˆ + 2
3
√
sˆ∗
)]
exp
[
λˆ(sˆ+ sˆ∗)
(
ωˆ + 2
3
√
sˆ+ sˆ∗
)] , (46)
where H is the unit step function and
tˆc(sˆ) = sˆ+ 2ωˆ
(√
sˆ+ sˆ∗ −
√
sˆ∗
)
(47)
17
is analogous to a “first-passage-time” for the formation of size-sˆ clusters.
To solve for the subsequent concentrations, we take advantage of the Cauchy data by
initializing all characteristic curves along the curve (tˆc(sˆ), sˆ) given by Eq. 47, thereby setting
cˆn = 0 at the left endpoint. Hence, each point (sˆ, tˆ) such that sˆ ≥ sˆ′ = sˆn, and tˆ ≥ tˆc(sˆ) lies
uniquely on a single curve originating from√
sˆ(tˆ0) + sˆ∗ =
√
sˆ′
√
sˆ+sˆ∗+
√
sˆ′√
sˆ+sˆ∗−
√
sˆ′
exp
[
tˆ−sˆ−2ωˆ(√sˆ+sˆ∗−
√
sˆ∗)
ωˆsˆ′
]
+ 1
√
sˆ+sˆ∗+
√
sˆ′√
sˆ+sˆ∗−
√
sˆ′
exp
[
tˆ−sˆ−2ωˆ(√sˆ+sˆ∗−
√
sˆ∗)
ωˆsˆ′
]
− 1
. (48)
As growth of the mineral phase occurs more quickly in the unshielded clusters than in
the shielded clusters, the sˆ− tˆ characteristics propagate quickest in the unshielded clusters.
Hence, the hierarchy supp(cˆn) ⊆ supp(cˆn−1) ⊆ · · · ⊆ supp(cˆ0) holds. In fact, the supports
of all functions cˆn are equal, as necessitated by the coupling defined by the right-hand-side
of Eq. 33. The creation of size-sˆ clusters of shielding n is driven more by the shielding of
“n − 1 clusters” rather than the growth of “n clusters.” We use this fact, along with the
presence of an exponential term within the exact differential of the right hand side of Eq. 45
to formulate the ansatz
cˆn(sˆ, tˆ) = H
(
tˆ− tˆc(sˆ)
)
gn(sˆ, tˆ) exp
[
−λˆ(sˆ+ sˆ∗)
(
ωˆ +
2
3
√
sˆ+ sˆ∗
)]
exp
[
λˆsˆ∗
(
ωˆ +
2
3
√
sˆ∗
)]
,
(49)
where
gn(u) = 2λˆ
u2 + ωˆu− sˆn
(u2 − sˆn)λˆωˆsˆn+1
×
∫ u
√
sˆ(tˆ0)+sˆ∗
q2(q2 − sˆn)λˆωˆsˆngn−1(q)dq. (50)
According to Eq. 46,
g0(u) =
ωˆ + u
u
√
sˆ∗
ωˆ +
√
sˆ∗
. (51)
For solving gn(sˆ, tˆ), the lower bound for the integral in Eq. 50 is taken from Eq. 48. For
solving the next equation gn+1(sˆ, tˆ), all instances of sˆ, tˆ reparameterized by the variable u
using Eq. 48.
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The iterated integrals of Eq. 50 can be solved numerically through standard quadrature
methods. Here we find some properties of the solutions to these equations before exploring
their steady-state behavior, which is of the most interest to us.
First, there is the question of whether these equations are well-posed. For u near
√
sˆn,
one can invoke L’Hopital’s rule on Eq. 50 to find that
lim
u↘√sˆn
gn(u) =
λˆωˆ
√
sˆn
λˆωˆsˆn + 1
= O(1).
So, the solutions are bounded on the left. Now, we seek to find pointwise bounds for the
solution away from the left boundary (for u >
√
sˆn). We note that the lower bound of the
integral term in Eq. 50, given by Eq. 48, approaches
√
sˆn as t→∞. Since the integrand is
non-negative, the solution is bounded from above by the steady state solution
gn(u) = 2λˆ
u2 + ωˆu− sˆn
(u2 − sˆn)λˆωˆsˆn+1
×
∫ u
√
sˆ(tˆ0)+sˆ∗
q2(q2 − sˆn)λˆωˆsˆngn−1(q)dq
≤ 2λˆ u
2 + ωˆu− sˆn
(u2 − sˆn)λˆωˆsˆn+1
×
∫ u
√
sˆn
q2(q2 − sˆn)λˆωˆsˆngn−1(q)dq
≡ g∞n (u). (52)
By repeated applications of the Cauchy-Schwarz inequality, one sees that the integral
term in Eq. 52 satisfies the inequalities∫ u
√
sˆn
q2(q2 − sˆn)λˆωˆsˆngn−1(q)dq
≤
[∫ u
√
sˆn
q4(q2 − sˆn)2λˆωˆsˆndq
]1/2
||g∞n−1||L2(√sˆn,u)
≤
[
(u2 − sn)4λˆωˆsˆn+1
4λˆωˆsˆn + 1
]1/4 [
u8 − s4n
8
]1/4
||gn−1||L2(√sˆn,u).
This computation gives us the pointwise bound on g∞n ,
g∞n (u) ≤
2λˆ
(4λˆωˆsˆn + 1)1/4
u2 + ωˆu− sˆn
(u2 − sˆn)3/4
×
[
u8 − sˆ4n
8
]1/4
||gn−1||L2(√sˆn,u).
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Using the fact that g∞0 (u) = O(1), it is easy to see by induction that gn(u) is bounded and
smooth (behaving locally like a polynomial with order controlled by n) for u >
√
sˆn, where
it is of-note that g∞n is bounded also in the vicinity of
√
sˆn. Hence, by Eq. 49, each solution
of cn(s, t) is Schwartz-class, for all t ≥ 0.
C. Steady-state behavior
Our interest is in long-term behavior of the system. Observe that the solutions of Eq. 49
contain an exponential multiplicative factor that represents regulatory shielding. This shield-
ing is strong provided that the term in the exponential is large, which is the case when the
inhibition ratio obeys
λˆ(1 + sˆ∗)3/2  1. (53)
In physical units, this criterion can be expressed succinctly in terms of the concentration of
FA protein needed,
φ∞  D
DFA
ρ∞ − ρs
mp
, (54)
where mp is critical number of Posner clusters in a pure-mineral cluster at sedimentation.
Note that if this condition were not to hold then a significant number of clusters of sedimen-
tation size would form. Sedimentation would then occur until exhaustion of supersaturated
species. In our subsequent analysis, we will assume that this condition holds.
Since the overall solution is tapered by the exponential term which goes as s3/2, or as the
volume, we are most interested in the behavior of g∞n (u) in the vicinity of
√
sn. In this limit,
we use the binomial theorem to approximate the integrals of the general form, for a, b ∈ R,∫ u
√
sˆn
q2(q2 − sˆn)λˆωˆsˆnqa(q2 − sˆn)bdq
=
√
sˆa+1n
2
∫ u2−sˆn
0
xλˆωˆsˆn+b
(
1 +
x
sn
)(a+1)/2
dx
=
√
sˆa+1n
2
[
(u2 − sˆn)λˆωˆsˆn+b+1
λˆωˆsˆn + b+ 1
+O
(
(u2 − sˆn)λˆωˆsˆn+b+2
)]
. (55)
Eq. 55 allows us to evaluate g∞1 to the leading order
g∞1 (u) ≈
√
sˆ∗
ωˆ +
√
sˆ∗
λˆ(
√
sˆ1 + ωˆ)
λˆωˆsˆ1 + 1
[
(u2 − sˆ1) + ωˆu
]
.
(56)
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Through an inductive argument, one finds that for n ≥ 1,
g∞n (u) ≈ (u2 − sˆn + ωˆu)
√
sˆ∗
ωˆ +
√
sˆ∗
× 1
sˆ1
n∏
j=1
λˆ((sˆj − sˆj−1)
√
sˆj + sˆjωˆ)
λˆωˆsˆj + 1
. (57)
We retain both u2 − sn and ωˆu in this expression because it is unclear which term is large.
As n increases however, the ωˆu term will begin to dominate. This fact implies that surface-
limited effects arise for large clusters, contrary to the situation for most other nucleation
problems.
D. Rate of FA consumption
Since we know the rate of protein association as a function of n (the number of bound
proteins) and s (the surface area of the mineral phase), we can compute the total rate of FA
consumption. Denote Rjk the cumulative rate of mineral consumption in shielding particles
of j FA monomers with size s ∈ (sk, sk+1). We derive this rate first for the shielding of
unshielded clusters of size at most s1, R00. Returning back to an integer parameterization
of the size, it is clear that the total rate of consumption of FA for these clusters follows
R00 =
m(s1)∑
m=m(s∗)
λ
√
s(m)c∞0 (s(m)). (58)
The sum in Eq. 58 can be approximated by a left-Riemann integral so that
m(s1)∑
m=m(s∗)
λ
√
s(m)c∞0 (s(m)) ≈∫ m(s1)
m(s∗)
λ
√
s(m)c∞0 (s(m))dm. (59)
After transformation from m back to s, one finds that
R00 ≈ λ√
16v¯2pi
∫ s1
s∗
sc∞0 (s)ds. (60)
Generalizing this result, it is easy to see that
Rnj ≈ λ√
16v¯2pi
∫ sj+1
sj
sc∞n (s)ds. (61)
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FIG. 5: Steady-state cluster concentration c∞n (s) and domain decomposition for computing
the protein consumption rate. Green shading (darker is more concentrated) corresponds to increased
steady-state concentration of mineral clusters of the particular size (given by horizontal axis) with the given
number of attached FA proteins (given by the vertical axis). In the asymptotic case of strong shielding
(Eq. 54), an exponential decay of concentration is seen according to size. From this solution, an overall
consumption rate of FA protein can be computed by summing over the attachment rates Rnj , where Rnj
refers to the rate of protein consumption by clusters of n bound proteins of size sj to sj+1.
The total consumption rate of FA protein follows
R ≈
at nucleation︷ ︸︸ ︷
λ
√
s∗c∞0 (s∗) +
∞∑
n=0
∞∑
j=n
Rnj (62)
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where the first term represents FA consumed in the instantaneous shielding of critical clus-
ters. Substituting Eq. 49 yields
R ≈ λ√s∗c∞0 (s∗)
{
1 + exp
[
λs∗
α
(
ω +
2
3
√
s∗
)]
×
∞∑
n=0
∫ ∞
sn
sg∞n (u(s))√
16v¯2s∗pi
exp
[
−λs
α
(
ω +
2
3
√
s
)]
ds
}
, (63)
where u(s) =
√
s/(sp − s∗). We approximate the integrals in Eq. 63 using the change of
variables
ξ =
λs
α
(
ω +
2
3
√
s
)
,
which we invert to find that
s =
(
3α
2λ
ξ
)2/3
− ω
(
3α
2λ
ξ
)1/3
+O(ω2)
dξ =
λ
α
(
ω +
√
s
)
ds
=
λ
α
[(
3α
2λ
ξ
)1/3
+
ω
2
+O(ω2)
]
ds. (64)
For n ≥ 1, we evaluate the integrals in Eq. 63,
∫ ∞
sn
sg∞n (u(s))√
16v¯2s∗pi
exp
[
−λs
α
(
ω +
2
3
√
s
)]
ds
=
1√
16v¯2s∗pi
√
s∗
ω +
√
s∗
1
s1
n∏
j=1
λ((sj − sj−1)√sj + sjω)
λωsj + α
×
∫ ∞
λsn
α (ω+
2
3
√
sn)
s(s− sn + ω
√
s)
λ
α
((
3α
2λ
ξ
)1/3
+ ω
2
+O(ω2)
)e−ξdξ. (65)
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We approximate the integral in Eq. 65 by a sum of incomplete Gamma functions Γ(a, x),∫ ∞
λsn
α (ω+
2
3
√
sn)
s(s− sn + ω
√
s)
λ
α
((
3α
2λ
ξ
)1/3
+ ω
2
+O(ω2)
)e−ξdξ
=
α
λ
∫ ∞
λsn
α (ω+
2
3
√
sn)
{(
3α
2λ
ξ
)
+ sn
(
3α
2λ
ξ
)1/3
− ω
[
5
2
(
3α
2λ
ξ
)2/3
− sn
2
]
+O(ω2)
}
e−ξdξ
∼ 3α
2
2λ2
Γ
(
2,
λsn
α
(
ω +
2
3
√
sn
))
+ sn
(
3α4
2λ4
)1/3
Γ
(
4
3
,
λsn
α
(
ω +
2
3
√
sn
))
− 5snαω
2λ
(
3α
2λ
)2/3
Γ
(
5
3
,
λsn
α
(
ω +
2
3
√
sn
))
+
αsnω
2λ
Γ
(
1,
λsn
α
(
ω +
2
3
√
sn
))
, (66)
where the remainder term is exponentially small by rationale of Watson’s Lemma. For
n = 0, we have ∫ ∞
s∗
sg∞0 (u(s))√
16v¯2s∗pi
exp
[
−λs
α
(
ω +
2
3
√
s
)]
ds
=
1√
16v¯2s∗pi
√
s∗
ω +
√
s∗
×
∫ ∞
s∗
(
s+ ω
√
s
)
exp
[
−λs
α
(
ω +
2
3
√
s
)]
ds (67)
=
1√
16v¯2s∗pi
√
s∗
ω +
√
s∗
× α
λ
∫ ∞
λs∗
α
(
ω+
2
√
s∗
3
)
[(
3α
2λ
ξ
)1/3
− ω
2
+O(ω2)
]
e−ξdξ
∼ α
λ
√
16v¯2s∗pi
√
s∗
ω +
√
s∗
{(
3α
2λ
)1/3
Γ
(
4
3
,
λs∗
α
(
ω +
2
√
s∗
3
))
− ω
2
Γ
(
1,
λs∗
α
(
ω +
2
√
s∗
3
))}
. (68)
In the regime where λ/α → ∞, no clusters of size greater than s∗ form, and the rate of
FA consumption matches the nucleation rate for ACP. Conversely, if clusters of size greater
than s1 form, the FA consumption rate is strictly greater than the ACP nucleation rate.
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E. Parameterization
As we have mentioned, normal physiological calcium concentrations exceed supersatura-
tion relative to the most thermodynamically stable phase of calcium phosphate. In fact, as
we shall see, they also exceed supersaturation relative to ACP.
Normal serum free ionic Ca2+ concentration varies between 1.2mM and 1.3mM [38],
and normal total serum phosphate concentration varies between 1.12mM and 1.45mM. At
pH = 7.4, one finds using the Henderson-Hasselbalch equation that the concentration of
free PO3–4 lies between 3.7 and 4.9 nM. Various studies have explored the solubility of ACP
relative to concentrations of its constituent ions (Ca2+, PO3–4 ). By empirical formula, ACP
has the negative-log10-solubility pKs = 3pCa + 2pPO4 ≈ 26 at 310K and pH= 7.4 [39].
Using this calculation, one may compute the supersaturation relative to ACP,
S(0) =
(
[Ca2+]3[PO34−]2
10−26
)1/5
. (69)
Hence, the supersaturation ratio is approximately S(0) ≈ 1.3 in normal conditions.
Estimates for the molecular weight of FA range from 51− 67kDa, while the usual serum
concentrations of FA range from 0.5 − 1.0g/L. Thus, FA ranges in concentration between
7µM−19µM in normal situations. We assume that mp = O(102), where it notable that a
single FA protein shields approximately 102 Posner clusters [22]. For context, a cluster of
size m = 100 corresponds to a diameter of approximately 4nm, assuming hexagonal close
packing and using v¯ = 0.3nm3 [22]. A diameter of 4nm is similar in extent to the size of FA,
which has been measured to have a hydrodynamical radius of 4.3nm [40]. We also note here
that the radius of a PC is approximately 0.4nm, so the ratio of the diffusivities between a
PC monomer and FA molecule (D/DFA), is approximately 10.
To estimate the concentration of PC monomers (ρ∞), we rely on indirect evidence as pre-
cise quantification of these clusters does not appear to have been performed in the literature.
We note that a study by Chughtai et al. [41] found that in physiological conditions approx-
imately 6% of solution Ca2+ is present in calcium-phosphate complexes. A separate study
has found that approximately 50% of calcium phosphate complexes have size consistent with
Posner’s cluster [42]. An ACP nucleation study using 2.5mM free Ca2+ and 1mM K2HPO4
found spherical clusters of approximately 30 − 80nm in diameter after 1hr [6]. Assuming
that the 80nm size corresponds to a cluster that nucleated soon after t = 0, one finds that
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the concentration of PCs is at least 2nM in their preparation. Using this value, we estimate
the an equilibrium constant for the formation of PCs
keq =
ρ∞
[Ca2+]3[PO3−4 ]2
, (70)
finding that pkeq ≈ −16. This compution estimates nanomolar-range concentrations for PCs
in the physiological range that we defined above.
With these rough estimates in mind, we may approximate an “inhibition-ratio” from
Eq. 53 as
I =
mpDFAφ∞
Dρ∞
≈ O(103). (71)
The concentration of post-nuclear clusters is exponential in this ratio, suggesting that large
values for I would inhibit calcification. We turn now to assays of calcification inhibition in
order to validate this computation.
Heiss et al. [43] assessed the inhibition of sedimentation in a highly supersaturated solu-
tion of 20mM Ca2+ and 6mM Na2HPO4 in a closed system. For this system, Eq. 70 provides
an estimate of ρ∞ = 2.5 × 10−5M. At 20µM, corresponding to I = O(102), FA was shown
to inhibit sedimentation fully over a time interval of days. At 1.5µM, corresponding to
I = O(101), FA was seen to initially inhibit sedimentation, but only for a period of two
hours. In the latter case, we expect two things to be occurring. First, because the exper-
iments are conducted in closed systems, exhaustion of FA is occurring over the long time
span. Second, inhibition is exponentially weaker than it is in physiological settings implying
a proportionally quicker rate of sedimentation.
IV. DISCUSSION
A. Protein consumption rate and implications
The quantity R sets a minimum replenishment rate for new FA protein in order to
maintain a steady concentration of FA, and hence colloidal stability. As seen in Eq. 26,
the parameter λ is present in the denominator of c∞0 (s∗). As a result, to the leading order,
R increases as λ decreases. Failure to maintain this replenishment rate leads to decrease in
φ∞, the concentration of FA. A drop in φ∞ further decreases λ, thereby further exacerbating
the situation (the less FA available, the more that is needed). Effectively, in the regime where
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calcium and phosphate concentrations remain supersaturated, the number of FA molecules
required to buffer each nucleating mineral particle increases as the concentration of FA
decreases.
Thus, even a small destabilization in FA replenishment can feed-forward to avalanche
into catastrophic calcium phosphate sedimentation. This observation explains the experi-
mental finding that serum FA is often significantly depressed in systems exhibiting ectopic
calcification, yet plentiful in the sedimented plaques [44].
B. Assumptions, Limitations, and Extensions
In our theoretical treatment of this topic, we have made some key simplifying assump-
tions. Correspondingly, we have also limited the scope of our formulation and results. We
reiterate that we are primarily interested in the earliest stages of the mineralization process,
immediately after nascent nuclei have overcome the kinetic barrier and progression is gov-
erned by thermodynamic considerations. For this reason, we do not consider later phases of
calcium phosphates, as well as their nucleation through heterogeneous nucleation involving
ACP precursors [19]. It is notable, however, that the transformations of calcium phosphate
from ACP to HA have been a rich topic of research, and FA protein is known to interact
with these phases as well, just as it interacts with ACP [40].
Biologically, we also assume that the specific structure of FA is important in two ways.
First, its hydrodynamical mobility determines the rate at which it is able to interact with
mineral clusters. Second, its precise biochemical structure determines its propensity for
strong interactions with post-nuclear clusters. We have assumed this mechanism to be the
primary mechanism for FA-based inhibition for several reasons.
Mainly, this mechanism has been suggested in the experimental literature [28]. Alterna-
tively, FA has been reported to be able to bind calcium ions directly [26], and hypothesized
to bind pre-nucleation clusters (Posner’s clusters) directly [22]. Yet, binding free calcium
ions directly would not inhibit nucleation without decreasing supersaturation. Binding of
pre-nucleation clusters would decrease the nucleation rate for calcium phosphates, running
counter to experimental evidence [28].
Aside from the experimental evidence, there are apparent advantages to the solubilizing of
post-nuclear particles as both an effective and efficient strategy for controlling sedimentation
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in super-saturated systems. While binding of pre-nucleation clusters would inhibit nucleation
by increasing the energy barrier, it would require more inhibitory proteins to work because
pre-nucleation clusters form at quicker rates than post-nucleation clusters. Experimental
and theoretical evidence has confirmed the presence and stability of Posner’s clusters in
biological solutions. In our formulation, we assume that pre-nucleation clusters exist in
quasi-steady equilibrium with free calcium and phosphate. We also assume that FA–free
calcium and FA–pre-nucleation cluster interactions are weak and reversible so that we may
ignore them.
It is this specificity of mechanism that makes FA a potent calcification inhibitor. Uniquely,
experiments have shown that FA is the crucial protein for in-vivo mineralization inhibition.
While other macromolecules such as albumin are known to interact with calcium phosphates,
their physical attributes make them insufficient for this task.
Albumin acts as a buffering agent for calcium in blood, helping to maintain Ca2+ concen-
tration in an analogous manner to maintenance of free H+ ion concentration by pH buffers.
For purposes of this study, the main effect of albumin is in setting the far-field equilibrium
concentration of Ca2+ and hence mineral monomers. We are ignoring interactions between
the regulatory FA protein and other plasma proteins such as albumin. Although lacking
in intrinsic capability, albumin has been shown to enhance the inhibitory properties of FA
protein [45], however, their main effect is in later-stage stabilization of complexes containing
multiple protein-mineral clusters [43].
In this manuscript we have also ignored other possible contributing factors to the overall
mineralization process including interactions with other ions such as sodium, chloride, mag-
nesium, zinc, or H+/OH−. While these ions have been shown to influence mineralization,
their importance in the early stages of nucleation is unclear.
We also have not considered secondary interactions between mineral-FA hybrids, or the
formation of calciprotein polymers. One of the goals of the present study has been to
determine the content of the individual calciprotein monomers (the protein-mineral hybrid
complexes we study in this manuscript). Observations by Wald et al. [46] have shown that the
stability and size of these secondary structures varies with the concentration of FA present
in the system. A possible cause for this effect is the variations in the mineral to protein
ratio in the clusters that we form in our model. The understanding of these calciprotein
monomers gained from this study should prove useful in better-understanding the kinetics
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behind the formation of calciprotein polymers as well as subsequent phase transitions.
Finally, while we have made an attempt to parameterize our model based on quantitative
results from past literature, our numerical estimates remain rough guides and further exper-
imentation is likely needed more-accurately parameterize our model. In particular, as the
precise mechanism for calcium phosphate nucleation becomes better known, it will become
easier to characterize the precise nucleation barrier and nucleation rate of calcium phosphate
in order to better-understand the FA consumption rate. We have assumed for instance that
the Posner cluster is the pre-nucleation cluster for this system, but recent literature has
been mixed with respect to this hypothesis. We would like to emphasize, however, that our
formulation is independent of the precise nature of these clusters as the bulk of our analyses
focus on post-nucleation events.
Looking more broadly at our work, the methodology that we have developed in this
manuscript has potential in explaining a variety of solubility problems throughout biology.
As an example, the system of stabilization, transport, and clearance of lipid molecules by
HDL and LDL bears striking resemblance to the calcium-phosphate-FA system that we have
analyzed in this manuscript. The formation of protein-non-protein complexes or colloids is
a widespread feature of the homeostasis of solutions in biology.
V. SUMMARY
In this manuscript we have utilized classical nucleation theory to provide a quantitative
description of the growth of calcium phosphate nanoparticles interacting with a shielding
protein. In contrast with other theoretical work on similar systems, we have not neglected
possible surface-limiting regimes of the process. Our quantitative description of the process
provides an estimate of the critical concentration of shielding protein necessary for stable
long-term inhibition of calcification, as well as an estimate of the total rate that the protein
is consumed.
Critically, we have found that disruptions of the ability to maintain the concentration
of FA leads to increased overall consumption of the protein, and hence, exhaustion and
sedimentation.
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